<DOC>
	<DOCNO>NCT00942344</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy fix combination amlodipine ( 5mg 10mg ) losartan ( 50 mg 100 mg ) , amlodipine losartan alone reduce blood pressure . The study investigate dose response relationship combination monotherapies .</brief_summary>
	<brief_title>Efficacy Safety Amlodipine Losartan Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients age 18 75 Patients essential hypertension { 95 mmHg ≤ sitDBP &lt; 115 mmHg end placebo runin treatment period } Patients mean sitSBP ≥ 200 mmHg Patients know hypersensitivity Dihydropyridine angiotensin II receptor blocker Patients secondary hypertension suspect secondary hypertension Patients malignant hypertension Patients receive medication possible interaction study drug Patients uncontrolled diabetes Patients severe heart disease severe cerebrovascular disease Patients clinically significant hematological test result , renal disease ( serum creatinine ) liver disease ( ALT AST ) Patients history malignant disease Patients history autoimmune disease Women positive pregnancy test result , breast feeding intention pregnancy trial Patients inappropriate include study population due reason discretion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Amlodipine</keyword>
	<keyword>Losartan</keyword>
	<keyword>Hypertension</keyword>
</DOC>